Pharmacological characterization of anaphylaxis-like shock responses induced in mice by mannan and lipopolysaccharide

International Immunopharmacology

Volumn 9, Issue 13-14, 2009, Pages 1518-1524

  Funayama, Hiromi ^a,b   Huang, Ling ^a   Sato, Tadasu ^a   Ohtaki, Yuko ^a   Asada, Yoshinobu ^b   Yokochi, Takashi ^c   Takada, Haruhiko ^a   Sugawara, Shunji ^a   Endo, Yasuo ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TSURUMI UNIVERSITY   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Complements; Lipopolysaccharide; Mannan; Platelet; Platelet activating factor; Shock

Indexed keywords

[2 METHOXY 3 (N OCTADECYLCARBAMOYLOXY)PROPYL] (2 THIAZOLIOETHYL) PHOSPHATE; COMPLEMENT COMPONENT C5 INHIBITOR; K 76; LIPOPOLYSACCHARIDE; MANNAN; MURAMYL DIPEPTIDE; THROMBOCYTE ACTIVATING FACTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; IMMUNE RESPONSE; KLEBSIELLA; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; THROMBOCYTE;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; ANAPHYLAXIS; ANIMALS; BLOOD PLATELETS; COMPLEMENT INACTIVATING AGENTS; FEEDBACK, PHYSIOLOGICAL; HYDROXAMIC ACIDS; INJECTIONS, INTRAVENOUS; KLEBSIELLA; LIPOPOLYSACCHARIDES; MALE; MANNANS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; PHOSPHOLIPID ETHERS; PLATELET AGGREGATION INHIBITORS; SACCHAROMYCES CEREVISIAE; TOLL-LIKE RECEPTOR 2;

EID: 70449084698     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.09.006     Document Type: Article

References (58)

1. Takada H., and Galanos C. Enhancement of endotoxin lethality and generation of anaphylactoid reactions by lipopolysaccharides in muramyl-dipeptide-treated mice. Infect Immun 55 (1987) 409-413
2. Takada H., Hirai H., Fujiwara T., Koga T., Ogawa T., and Hamada S. Bacterioides lipopolysaccharides (LPS) induce anaphylactoid and lethal reactions in LPS-responsive and -non-responsive mice primed with muramyl dipeptide. J Infect Dis 162 (1990) 428-434
3. Poltrak A., He X., Smirnova I., Liu M.-Y., Van Huffel C., Du X., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr Mice. Science 282 (1998) 2085-2088
4. Qureshi S.T., Larviére L., Leveque G., Clermont S., Moore K.J., Gros P., et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189 (1999) 615-625
5. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. J Biol Chem 278 (2003) 5509-5512
6. Girardin S.E., Boneca I.G., Girardin V., SE B., Viala J., Chamaillard M., et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278 (2003) 8869-8872
7. Kawabata Y., Yang S., Yokochi T., Matsushita M., Fujita T., Shibazaki M., et al. Complement system is involved in anaphylactoid reaction induced by lipopolysaccharide in muramyldipeptide-treated mice. Shock 14 (2000) 572-577
8. Ohba M., Shibazaki M., Sasano T., Inoue M., Takada H., and Endo Y. Platelet responses and anaphylaxis-like shock induced in mice by intravenous injection of whole cells of oral streptococcci. Oral Microbiol Immunol 19 (2004) 26-30
9. Shibazaki M., Nakamura M., and Endo Y. Biphasic, organ-specific, and strain-specific accumulation of platelets induced in mice by a lipopolysaccharide from Escherichia coli and its possible involvement in shock. Infect Immun 64 (1996) 5290-5294
10. Endo Y., Shibazaki M., Nakamura M., and Takada H. Contrasting effects of lipopolysaccharides (endotoxins) from oral black-pigmented bacteria and Enterobacteriaceae on platelets, a major source of serotonin, and on histamine-forming enzyme in mice. J Infect Dis 175 (1997) 1404-1412
11. Shibazaki M., Kawabata Y., Yokochi T., Nishida A., Takada H., and Endo Y. Complement-dependent accumulation and degradation of platelets in the lung and liver induced by injection of lipopolysaccharide. Infect Immun 67 (1999) 5186-5191
12. Zhao L., Ohtaki Y., Yamaguchi K., Matsushita M., Fujita T., Yokochi T., et al. LPS-induced platelet response and rapid shock in mice: contribution of O-antigen region of LPS and involvement of the lectin pathway of the complement system. Blood 100 (2002) 3233-3239
13. Ellis M.E., Al-Abdely H., Sandridge A., Greer W., and Ventura W. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis 32 (2001) 50-62
14. Nelson R.D., Shibata N., Podzorski R.P., and Herron M.J. Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action. Clin Microbiol Rev 4 (1991) 1-19
15. Ashman R.B., and Papadimitriou J.M. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol Rev 59 (1995) 646-672
16. Tada H., Nemoto E., Shimauchi H., Watanabe T., Mikami T., Matsumoto T., et al. Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and Toll-like receptor 4-dependent manner. Microbiol Immunol 46 (2002) 503-512
17. Roeder A., Kirschning C.J., Rupec R.A., Schaller M., and Korting H.C. Toll-like receptors and innate antifungal responses. Trends Microbiol 12 (2004) 44-49
18. Netea M.G., Gow N.A., Munro C.A., Bates S., Collins C., Ferwerda G., et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest 116 (2006) 1642-1650
19. Calderone R.A., and Braun P.C. Adherence and receptor relationship of Candida albicans. Microbiol Rev 55 (1991) 1-20
20. Maisch P.A., and Calderone R.A. Role of surface mannan in the adherence of Candida albicans to fibrin-platelet clots formed in vitro. Infect Immun 32 (1981) 92-97
21. Lopes-Bezerra L.M., and Filler S.G. Endothelial cells, tissue factor and infectious diseases. Braz J Med Biol Res 36 (2003) 987-991
22. Cutler J.E., Friedman L., and Milner K.C. Biological and chemical characterization of toxic substances from Candida albicans. Infect Immun 6 (1972) 616-627
23. Kind L.S., Kaushal P.K., and Drury P. Fatal anaphylaxis-like reaction induced by yeast mannan in nonsensitized mice. Infect Immun 5 (1972) 180-182
24. Waki I., and Kimura M. Possible role of IgE-constituent carbohydrate in the mediation of histamine release. Jpn J Pharmacol 28 (1978) 39-45
25. Nagase T., Mikami T., Suzuki S., Schuerch C., and Suzuki M. Lethal effect of neutral mannan fraction of bakers' yeast in mice. Microbiol Immunol 28 (1984) 997-1007
26. Mikami T., Fukushi K., Ishitani M., Ishitani K., Suzuki S., and Suzuki M. Induction of platelet-activating factor in mice by intravenous administration of neutral fraction of bakers' yeast mannan. Lipid 26 (1991) 1404-1407
27. Nagi-Miura N., Shingo Y., Kurihara K., Adachi Y., Suzuki K., and Ohno N. Involvement of platelet activating factor, histamine and serotonin in acute lethal shock induced by Candida albicans water-soluble extracellular polysaccharide fraction (CAWS) in mice. Biol Pharm Bull 30 (2007) 1354-1357
28. Namm D.H., Tadepalli A.S., and High J.A. Species specificity of the platelet response to 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine. Thromb Res 25 (1982) 341-350
29. Inarrea P., Gomez-Cambronero J., Nieto M., and Crespo M.S. Characteristics of the binding of platelet-activating factor to platelets of different animal species. Eur J Pharmacol 105 (1984) 309-315
30. Chao W., and Olson M.S. Platelet-activating factor: receptors and signal transduction. Biochem J 292 (1993) 617-629
31. Ishii S., and Shimizu T. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res 39 (2000) 41-82
32. Yoshida A., Ohba M., Wu X., Sasano T., Nakamura M., and Endo Y. Accumulation of platelets in the lung and liver and their degradation following antigen-challenge in sensitized mice. Br J Pharmacol 137 (2002) 146-152
33. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall component. Immunity 11 (1999) 443-451
34. Obayashi T., Tamura H., Tanaka S., Ohki M., Takahashi S., Arai M., et al. A new chromogenic endotoxin-specific assay using recombined Limulus coagulation enzymes and its clinical applications. Clin Chim Acta 149 (1985) 55-65
35. Yokochi T., Inoue Y., Yokoo J., Kimura Y., and Kato N. Retention of bacterial lipopolysaccharide at the site of subcutaneous injection. Infect Immun 57 (1989) 1786-1791
36. Hong K., Kinoshita T., Miyazaki W., Izawa T., and Inoue K. An anticomplementary agent, K-76 monocarboxylic acid: its site and mechanism of inhibition of the complement activation cascade. J Immunol 122 (1979) 2418-2423
37. Nagata Y., Nagahisa H., Aida Y., Okutomi K., Nagasawa T., and Todokoro K. Thrombopoietin induces megakaryocyte differentiation in hematopoietic progenitor FDC-P2 cells. J Biol Chem 270 (1995) 19673-19675
38. Nagata Y., Shozaki Y., Nagahisa H., Nagasawa T., Abe T., and Todokoro K. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis. Thromb Haemost 77 (1997) 808-814
39. Ohtaki Y., Shimauchi H., Yokochi T., Takada H., and Endo Y. In vivo platelet response to lipopolysaccharide in mice: proposed method for evaluating new antiplatelet drugs. Thromb Res 108 (2002) 303-309
40. Endo Y., and Nakamura M. The effects of lipopolysaccharide, interleukin-1 and tumour necrosis factor on the hepatic accumulation of 5-hydroxytryptamine and platelets in the mouse. Br J Pharmacol 105 (1992) 613-619
41. Van Rooijen N., and Sanders A. Liposome-mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 174 (1994) 83-93
42. Endo Y., Nakamura M., Nitta Y., and Kumagai K. Effects of macrophage depletion on the induction of histidine decarboxylase by lipopolysaccharide, interleukin 1 and tumour necrosis factor. Br J Pharmacol 114 (1995) 187-193
43. Yamaguchi Y., Yu Z., Kumamoto H., Sugawara Y., Kawamura H., Takada H., et al. Involvement of Kupffer cells in lipopolysaccharide-induced rapid accumulation of platelets in the liver and the ensuing anaphylaxis-like shock in mice. Biochem Biophys Acta (Mol Basis Dis) 1762 (2006) 269-275
44. Bross I.D.J. How to use ridit analysis. Biometrics 4 (1958) 18-38
45. Yu Z., Ohtaki Y., Kai K., Sasano T., Shimauchi H., Yokochi T., et al. Critical roles of platelets in lipopolysaccharide-induced lethality: effects of glycyrrhizin and possible strategy for acute respiratory distress syndrome. Int Immunopharmacol 5 (2005) 571-580
46. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
47. Maurer-Spurej E. Circulating serotonin in vertebrates. Cell Mol Life Sciences 62 (2005) 1881-1889
48. Herd C.M., and Page C.P. Pulmonary immune cells in health and disease: platelets. Eur Respir J 7 (1994) 1145-1160
49. Klinger M.H.F. Platelets and inflammation. Anat Embryol 196 (1997) 1-11
50. Männel D.N., and Grau G.E. Role of platelet adhesion in homeostasis and immunopathology. J Clin Pathol Mol Pathol 50 (1997) 175-185
51. Weyrich A.S., and Zimmerman G.A. Platelets: signaling cells in the immune continuum. Trends Immunol 5 (2004) 489-495
52. Meseguer J., Esteban M.Á., and Rodríguez A. Are thrombocytes and platelets true phagocytes?. Microscopy Res Technique 57 (2002) 491-497
53. Ohtaki Y., Yamaguchi K., Yu Z., Kumamoto H., Shimauchi H., Iwakura Y., et al. Hepatic platelet accumulation in Fas-mediated hepatitis in mice. International Immunopharmacol 9 (2009) 1071-1078
54. Kardis N.P., Kouraklis G., and Theocharis S.E. Platelet-activating-factor in liver injury: a relational scope. World J Gastroenterol 12 (2006) 3695-3706
55. Hikiji H., Takato T., Shimizu T., and Ishii S. The roles of prostanoids, leukotrienes, and platelet-activating factor in bone metabolism and disease. Prog Lipid Res 47 (2008) 107-126
56. Kulikov V.I., and Muzya G.I. Ether lipids and platelet-activating factor: evolution and cellular function. Biochemistry (Mosc) 61 (1997) 1103-1108
57. Choi I.H., Shin Y.M., Park J.S., Lee M.S., Han E.H., Chai O.H., et al. Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice. J Exp Med 188 (1998) 1587-1592
58. Ishii S., Kuwaki T., Nagase T., Maki K., Tashiro F., Sunaga S., et al. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med 187 (1998) 1779-1788